EPM2AIP1 and progressive myoclonus epilepsy: EPM2AIP1 plays a crucial role in Lafora disease (LD), a fatal form of progressive myoclonus epilepsy characterized by neurodegeneration and the presence of intracellular polyglucosan inclusions (Lafora bodies) in different tissues [39].